ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1145

Implementation of Web-Based Patient-Reported Outcome Measures (PROMs) in SLE Clinical Care: A Multi-Center Prospective Cohort Study

Shanthini Kasturi1, Lori Lyn Price1, David Curtis2, William Nowell3, Norma Terrin1, Jane Salmon4, Lisa Mandl4 and Timothy McAlindon1, 1Tufts Medical Center, Boston, MA, 2Global Healthy Living Foundation, New York City, 3Global Healthy Living Foundation, New York City, NY, 4Hospital for Special Surgery, New York, NY

Meeting: ACR Convergence 2020

Keywords: Cohort Study, Patient reported outcomes, quality of care, quality of life, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2020

Title: Patient Outcomes, Preferences, & Attitudes Poster II: Miscellaneous Rheumatic Diseases

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Patient-reported outcome measures (PROMs) are powerful tools which can highlight the patient experience of illness. Although PROMs are standard metrics in SLE clinical research, they are not routinely integrated in clinical care. Individuals with SLE are enthusiastic about the potential of PROMs to facilitate patient-centered care, but little is known about the utility and burden of implementing PROMs in SLE clinical encounters. The aim of this study was to assess the feasibility and impact of implementing web-based PROMs in the routine clinical care of outpatients with SLE.

Methods: Outpatients fulfilling 1997 ACR SLE classification criteria were enrolled in this longitudinal cohort study at two academic medical centers. Subjects completed PROMIS computerized adaptive tests at enrollment and prior to two consecutive routinely scheduled rheumatology visits using the ArthritisPower research registry mobile or web-based application. Score reports were shared with patients and providers before the visits. Patients and rheumatologists completed post-visit surveys evaluating the utility of PROMs in the clinical encounters.

Results: A total of 105 SLE patients and 16 rheumatologists participated in the study (Table 1). Subjects completed PROMs in 159 of 184 eligible encounters (86%, 95% CI 81 – 91) prior to study suspension due to the COVID-19 pandemic. Following baseline surveys, PROMs were completed for 90% (95% CI 82 – 95) of visit 1’s and 82% (95% CI 72 – 90) of visit 2’s. Nearly all PROMs (93%) were completed remotely. Patients and rheumatologists found that PROMs were useful (91% and 83% of encounters respectively) and improved communication (86% and 72%) (Table 2). Rheumatologists reported that PROMs impacted patient management in 51% of visits, primarily by guiding conversations (84%), but also by influencing medication changes (15%) and prompting referrals (10%). There was no statistically significant difference in visit length before (mean=19.5 minutes) and after (mean=20.4 minutes) implementation of PROMs (p=0.52).

Conclusion: The remote capture and subsequent integration of PROMs into clinical care was feasible in this diverse cohort of SLE outpatients. PROMs were useful to both patients and rheumatologists, promoting patient-centered care primarily by facilitating communication. The implementation of PROMs was not significantly associated with an increase in length of visits.

Table 1. Characteristics of Participants

Table 2. Benefits, Challenges, and Ideal Use of Patient-Reported Outcome Measures in Clinical Care


Disclosure: S. Kasturi, None; L. Price, None; D. Curtis, None; W. Nowell, None; N. Terrin, None; J. Salmon, UCB, 1, 2, BMS, 1, 2, Abbott, 1, Pfizer, 1, Johnson & Johnson, 1, Lilly, 1, Merck, 1, Regeneron, 1; L. Mandl, Annals of Internal Medicine, 9, UpToDate, 7, Regeneron, 2; T. McAlindon, Pfizer, 1, Sanofi Aventis US, 1, Kolon Tissuegene, 1, Samumed, 1, Seikagaku, 1, Kiniksa Pharmaceuticals, 1, Anika Therapeutics, 1.

To cite this abstract in AMA style:

Kasturi S, Price L, Curtis D, Nowell W, Terrin N, Salmon J, Mandl L, McAlindon T. Implementation of Web-Based Patient-Reported Outcome Measures (PROMs) in SLE Clinical Care: A Multi-Center Prospective Cohort Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/implementation-of-web-based-patient-reported-outcome-measures-proms-in-sle-clinical-care-a-multi-center-prospective-cohort-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/implementation-of-web-based-patient-reported-outcome-measures-proms-in-sle-clinical-care-a-multi-center-prospective-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology